In clinical practice, VCAM-1 expression has been reported to be correlated with poorer outcome in TNBC but also in other cancer type such as glioblastoma and ovarian cancer, and VCAM-1 imaging has been proposed as a tool for the assessment of tumor aggressiveness. This evidence concerns the gene VCAM1 and cancer.